BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33563583)

  • 21. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
    Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
    J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1.
    Jiang SP; Li ZR
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2028-2037. PubMed ID: 30915746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.
    Zhu T; Hu Z; Wang Z; Ding H; Li R; Wang J; Wang G
    Cell Biol Toxicol; 2023 Oct; 39(5):1923-1937. PubMed ID: 35246762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.
    Jiang J; Yang P; Guo Z; Yang R; Yang H; Yang F; Li L; Xiang B
    World J Surg Oncol; 2016 Oct; 14(1):278. PubMed ID: 27793160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p.
    Han S; Xue L; Wei Y; Yong T; Jia W; Qi Y; Luo Y; Liang J; Wen J; Bie N; Liang H; Liu Q; Ding Z; Yang X; Gan L; Huang Z; Chen X; Zhang B
    Adv Sci (Weinh); 2023 Jun; 10(17):e2207080. PubMed ID: 37096833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis.
    Liu X; Jiang F; Wang Z; Tang L; Zou B; Xu P; Yu T
    J Cell Mol Med; 2021 Jan; 25(1):96-109. PubMed ID: 33219752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
    Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
    Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
    Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
    J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
    O'Brien KP; Khan S; Gilligan KE; Zafar H; Lalor P; Glynn C; O'Flatharta C; Ingoldsby H; Dockery P; De Bhulbh A; Schweber JR; St John K; Leahy M; Murphy JM; Gallagher WM; O'Brien T; Kerin MJ; Dwyer RM
    Oncogene; 2018 Apr; 37(16):2137-2149. PubMed ID: 29367765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.
    Chen CL; Wu JC; Chen GY; Yuan PH; Tseng YW; Li KC; Hwang SM; Hu YC
    Mol Ther; 2015 Jan; 23(1):79-88. PubMed ID: 25023326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
    Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
    Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.